Skip to main content
. Author manuscript; available in PMC: 2017 Sep 15.
Published in final edited form as: Int J Cardiol. 2016 Jun 14;219:164–171. doi: 10.1016/j.ijcard.2016.06.045

Table 1.

Baseline demographic, medical, and depression characteristics by treatment arm* (N = 201)

Baseline Characteristic Usual Care (N=101) Collaborative Care (N=100) P
Demographics
 Age (in years) 63.1 SD=10.0 63.0 SD= 9.5 0.91
 Gender (female) 37 (36.6) 47 (47.0) 0.14
 Race (Caucasian) 71 (70.3) 76 (76.0) 0.36
 Education (12+ years) 88 (87.1) 89 (89.0) 0.68
Medical
 Current Smoker 20 (19.8) 28 (28.0) 0.17
 History of MI 72 (71.3) 49 (49.0) 0.001
 Diabetes 45 (44.6) 42 (42.0) 0.71
 Hypertension 90 (89.1) 87 (87.0) 0.64
 History of Revascularization 84 (83.2) 67 (67.0) 0.008
 Canadian Heart Class 0.96
  Asymptomatic 44 (62.0) 37 (60.6)
  Class 1, 2, or 3 11 (15.5) 9 (14.8)
  Class 4 16 (22.5) 15 (24.6)
Medications
 Statin 88 (87.1) 86 (86.0) 0.81
 Beta blocker 82 (81.1) 76 (76.0) 0.37
 Aspirin 93 (92.1) 87 (87.0) 0.24
 Calcium channel blocker 31 (30.7) 25 (25.0) 0.37
 ACE Inhibitor 60 (59.4) 61 (61.0) 0.82
 Diuretic 58 (57.4) 49 (49.0) 0.23
 Anxiolytic 17 (16.8) 19 (19.0) 0.69
Depression History
 Antidepressant at baseline 48 (47.5) 48 (48.0) 0.95
 Prior episodes of major depression 80 (79.2) 83 (83.0) 0.49
*

Continuous variables are reported as (mean, SD). Categorical variables represent number of patients (%).